Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcitriol for inflammatory markers after ischemic stroke
IRCT20210101049905N1Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jan 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of calcitriol in ischemic stroke (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoints: Erythrocyte sedimentation rate and C-reactive protein. Started Jan 2021; status: completed.
02
Drugs
calcitriol
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on IRCT20210101049905N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210101049905N1.